Authors: DeGruttola, V Dix, L D'Aquila, R Holder, D Phillips, A Ait-Khaled, M Baxter, J Clevenbergh, P Hammer, S Harrigan, R Katzenstein, D Lanier, R Miller, M Para, M Yerly, S Zolopa, A Murray, J Patick, A Miller, V Castillo, S Pedneault, L Mellors, J

Citation: V. Degruttola et al., The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan, ANTIVIR TH, 5(1), 2000, pp. 41-48

Authors: Gray, CM Lawrence, J Ranheim, EA Vierra, M Zupancic, M Winters, M Altman, J Montoya, J Zolopa, A Schapiro, J Haase, AT Merigan, TC

Citation: Cm. Gray et al., Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activatedT cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8(+) T cells, AIDS RES H, 16(14), 2000, pp. 1357-1369

Authors: Tulsky, JP Pilote, L Hahn, JA Zolopa, A Burke, M Chesney, M Moss, AR

Citation: Jp. Tulsky et al., Adherence to isoniazid prophylaxis in the homeless - A randomized controlled trial, ARCH IN MED, 160(5), 2000, pp. 697-702

Authors: Lawrence, J Schapiro, J Winters, M Montoya, J Zolopa, A Pesano, R Efron, B Winslow, D Merigan, TC

Citation: J. Lawrence et al., Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced persons, J INFEC DIS, 179(6), 1999, pp. 1356-1364